Pharmaceutical Executive Daily: Carvykti Demonstrates Sustained Remissions

Pharmaceutical Executive Daily: FDA Approves Breyanzi

Pharmaceutical Executive Daily: Mark Cuban's Push for Generic Drug Fee Waivers

Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER

Pharmaceutical Executive Daily: FDA's Agentic AI Deployment

Pharmaceutical Executive Daily: Lilly Reduces the Price of Zepbound

Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products

Pharmaceutical Executive Daily: Novartis Cuts 550 Jobs

Pharmaceutical Executive Daily: Moderna's $1.5 Billion Loan

Pharmaceutical Executive Daily: Tesaro and AnaptysBio's Legal Battle

Pharmaceutical Executive Daily: Novartis' North Carolina Manufacturing Hub

Pharmaceutical Executive Daily: Moderna's $140 Million Manufacturing Investment

Pharmaceutical Executive Daily: FDA's Approval of Epkinly

Pharmaceutical Executive Daily: Novo Nordisk's Leadership Restructure

Pharmaceutical Executive Daily: WeightWatchers Planning to Offer Wegovy Following Approval

Pharmaceutical Executive Daily: Dr. Richard Pazdur Appointed as Director CDER

Pharmaceutical Executive Daily: AstraZeneca Becomes UK's Largest Stock

Pharmaceutical Executive Daily: Wegovy Shows Potential to Treat MASH Patients

Raising Biomarker Awareness

Pharmaceutical Executive Daily: FDA Approves Darzalex Faspro